107 results on '"Anneren, G"'
Search Results
2. Noonan and cardio-facio-cutaneous syndromes: two clinically and genetically overlapping disorders
3. Growth hormone treatment in young children with Down's syndrome: effects on growth and psychomotor development
4. Sickness Absence in Swedish Parents of Children with Down's Syndrome: Relation to Self-Perceived Health, Stress and Sense of Coherence
5. Thyroid dysfunction in Down's syndrome: relation to age and thyroid autoimmunity
6. Growth hormone therapy in youngchildren with Down syndrome and a clinical comparison of Down and Prader-Willi syndromes
7. Incidence of Down’s Syndrome in Sweden During the Years 1968–1977
8. Identification of a 40 kb deletion in 3q23 causing the Blepharophimosis, Ptosis and Epicanthus inversus Syndrome (BPES)
9. Identification of a deletion in 3q23 causing the Blepharophimosis, Ptosis and Epicantus inversus Syndrome (BPES)
10. X-exome sequencing of 405 unresolved families identifies seven novel intellectual disability genes
11. 1p13.2 deletion displays clinical features overlapping Noonan syndrome, likely related to NRAS gene haploinsufficiency
12. P01.03: Reasons for pregnant women to accept or decline prenatal diagnosis for Down's syndrome
13. Preventing neural tube defects in Europe: A missed opportunity (vol 20, pg 393, 2005)
14. Normal growth hormone secretion in overweight young adults with Down syndrome
15. A SWI/SNF-related autism syndrome caused by de novo mutations in ADNP
16. P01.03: Women and partners coming for a first trimester combined (CUB) test; why they choose it, how are they informed, knowledge about Down's syndrome and their plans if Down's syndrome is diagnosed
17. A novel microdeletion syndrome at 3q13.31 characterised by developmental delay, postnatal overgrowth, hypoplastic male genitals, and characteristic facial features.
18. Growth retardation in down syndrome: thyroid disorders, coeliac desease and the effect of GH therapy
19. Maternal and neonatal factors and mortality in children with Down syndrome born in 1973-1980 and 1995-1998
20. Linkage analysis identifies the thyroglobulin gene region as a major locusfor familial congenital hypothyroidism.
21. Trisomy 4q syndrome: presentation of a new case and review of theliterature.
22. FISH-mapping of a 100-kb terminal 22q13 deletion.
23. Utilization of medical care among children with Down's syndrome
24. Swedish parents of children with Down's syndrome : Parental stress and sense of coherence in relation to employment rate and time spent in child care
25. First information and support provided to parents of children with Down syndrome in Sweden : clinical goals and parental experiences
26. Growth hormone treatment in patients with Down syndrome.
27. Growth hormone therapy in young children with Down's syndome and a clinical comparison of Down and Prader-Willi syndromes
28. Celiac disease in relation to immunologic serum markers, traced DQ antigens in Swedish children with Down syndrome.
29. The effect of growth hormone therapy on craniofacial growth and dental maturity in children with Down syndrome.
30. Origin of nondisjunction in trisomy 8 and trisomy 8 mosaicism.
31. Linkage analysis excludes familial congenital hypothyroidism from chromosome 21.
32. Monosomy 18q syndrome and atypical Rett syndrome in a girl with an interstitial deletion (18)(q21.1q22.3).
33. Boy with an interstitial 1q (q31q41) duplication confirmed by fluorescent in situ hybridisation.
34. A novel mutation (C201R) in the transmembrane domain of the Connexin 32 in severe X-linked Charcot-Marie-Tooth disease.
35. Hypervariable allelic expression patterns of the imprinted IGF2 gene in tumor cells.
36. Hypervariable allelic expression patterns of IGF2 in tumor cells
37. Linkage analysis excludes familial congenital hypothyroidism fromchromosome 21.
38. Identification and analysis of mutations in the Wilson disease genetype correlation, and functional analyses.
39. Differential effect of selenium supplementation on immunoglobulin levels in Down syndrome.
40. Indentification and analysis of mutations in the Wilson disease gene (ATP7B): Population frequencies; Genotype - Phenotype correlation; and Functional analyses
41. The impact of thyroid autoimmunity in children and adolescents with Down syndrome
42. Genetic and linkage analysis of familial congenital hypothyroidism: Exclusion of linkage to the TSH receptor gene.
43. Utilization of medical care among children with Down's syndrome
44. A new quantitative solution hybridisation-RNase protection assay for APP and APLP2 mRNA.
45. Statement for parents on Growth Hormone treatment for children with Down syndrome.
46. Deletion of chromosome 21 in a girl with congenital hypothyroidism and mild mental retardation : Molecular definition of the lesion
47. The genetics of primary nocturnal enuresis: Inheretance and suggestion of a major gene on chromosome 12
48. Growth and pubertal development in Down syndrome
49. The effect of growth hormone therapy on growth and mental development in children with Down syndrome
50. Noonan syndrome with café au lait spots and multiple lentigines syndrome are not linked to the Neurofibromatosis type I locus.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.